المؤلفون: Jacobus A. Burgers, Godefridus J. Peters, Egbert F. Smit, Elisa Giovannetti, Francesco Di Costanzo, Andrea Ardizzoni, Carmelo Tibaldi, Andrea Camerini, Fausto Barbieri, Marcello Tiseo, Andrew D. Vincent

المساهمون: Medical oncology laboratory, Pulmonary medicine, CCA - Innovative therapy, Tiseo, Marcello, Giovannetti, Elisa, Tibaldi, Carmelo, Camerini, Andrea, Di Costanzo, Francesco, Barbieri, Fausto, Burgers, Jacobus A., Vincent, Andrew, Peters, Godefridus J., Smit, Egbert F., Ardizzoni, Andrea

المصدر: Lung Cancer, 78(1), 92-99. Elsevier Ireland Ltd
Tiseo, M, Giovannetti, E, Tibaldi, C, Camerini, A, Di Costanzo, F, Barbieri, F, Burgers, J A, Vincent, A D, Peters, G J, Smit, E F & Ardizzoni, A 2012, ' Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed-carboplatin ', Lung Cancer, vol. 78, no. 1, pp. 92-99 . https://doi.org/10.1016/j.lungcan.2012.07.009Test

مصطلحات موضوعية: Male, Oncology, Cancer Research, Lung Neoplasms, non-small cell lung cancer (NSCLC), Pharmacology, Thymidylate synthase, Carboplatin, Antineoplastic Agent, Reduced Folate Carrier Protein, chemistry.chemical_compound, Gene Frequency, Glutamates, Retrospective Studie, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Allele, Aged, 80 and over, biology, Pharmacogenetic, Hazard ratio, Middle Aged, Treatment Outcome, Pemetrexed, Female, Glutamate, Human, medicine.drug, Adult, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Guanine, Genotype, Non-small cell lung cancer (NSCLC), Antineoplastic Agents, Polymorphism, Single Nucleotide, Internal medicine, medicine, Humans, Alleles, Methylenetetrahydrofolate Reductase (NADPH2), Aged, Neoplasm Staging, Retrospective Studies, Xeroderma Pigmentosum Group D Protein, Antineoplastic Combined Chemotherapy Protocol, business.industry, Proportional hazards model, Thymidylate Synthase, gamma-Glutamyl Hydrolase, MTHFR-C667T polymorphism, medicine.disease, Lung Neoplasm, chemistry, Methylenetetrahydrofolate reductase, biology.protein, business, Pharmacogenetics

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e75b870f6ebcd4b15db069e24f07cf1Test
https://doi.org/10.1016/j.lungcan.2012.07.009Test

المؤلفون: Ines J. Beumer, Elisa Giovannetti, Kees Smid, Robert Mauritz, Cees J. van Groeningen, Herbert M. Pinedo, Godefridus J. Peters

المساهمون: Medical oncology, Internal medicine, Medical oncology laboratory, CCA - Innovative therapy

المصدر: Mauritz, R, Giovannetti, E, Beumer, I J, Smid, K, van Groeningen, C J, Pinedo, H M & Peters, G J 2009, ' Polymorphisms in the Enhancer Region of the Thymidylate Synthase Gene Are Associated with Thymidylate Synthase Levels in Normal Tissues but Not in Malignant Tissues of Patients with Colorectal Cancer ', Clinical Colorectal Cancer, vol. 8, no. 3, pp. 146-154 . https://doi.org/10.3816/CCC.2009.n.024Test
Clinical Colorectal Cancer, 8(3), 146-154. Elsevier

مصطلحات موضوعية: Adult, Male, Colorectal cancer, Colon, Thymidylate synthase, Metastasis, Genotype, medicine, Humans, RNA, Messenger, RNA, Neoplasm, Allele, Gene, Aged, Aged, 80 and over, Polymorphism, Genetic, biology, Reverse Transcriptase Polymerase Chain Reaction, Liver Neoplasms, Gastroenterology, Rectum, Thymidylate Synthase, Middle Aged, medicine.disease, Prognosis, Primary tumor, Molecular biology, Phenotype, Enhancer Elements, Genetic, Treatment Outcome, Oncology, biology.protein, Cancer research, Female, Neoplasm Recurrence, Local, Colorectal Neoplasms

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::053976b58f3f2f3db5c3796910b595f6Test
https://doi.org/10.3816/ccc.2009.n.024Test

المؤلفون: Clara Lemos, Gl Scheffer, G. Giaccone, Elisa Giovannetti, Carmelo Tibaldi, G.J. Peters, T. van der Straaten, H-J Guchelaar, Pa Zucali, Alfredo Falcone, Armando Santoro, Yg Assaraf, Romano Danesi, Armida D'Incecco

المساهمون: Medical oncology, Medical oncology laboratory, Pathology, CCA - Innovative therapy

المصدر: Pharmacogenomics, 12(2), 159-170
Lemos, C, Giovannetti, E, Zucali, P A, Assaraf, Y G, Scheffer, G L, van der Straaten, T, D'Incecco, A, Falcone, A, Guchelaar, H J, Danesi, R, Santoro, A, Giaccone, G, Tibaldi, C & Peters, G J 2011, ' Impact of ABCG2 polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients ', Pharmacogenomics, vol. 12, no. 2, pp. 159-170 . https://doi.org/10.2217/pgs.10.172Test
Pharmacogenomics
Pharmacogenomics, 12(2), 159-170. Future Medicine Ltd.

مصطلحات موضوعية: Male, Oncology, Lung Neoplasms, Abcg2, gefitinib, Genome-wide association study, NSCLC, Carcinoma, Non-Small-Cell Lung, Genotype, ATP Binding Cassette Transporter, Subfamily G, Member 2, Precision Medicine, pharmacogenetics, biology, Middle Aged, Neoplasm Proteins, Treatment Outcome, embryonic structures, Toxicity, Molecular Medicine, Female, medicine.drug, Diarrhea, medicine.medical_specialty, ABCG2, animal structures, Antineoplastic Agents, Article, Gefitinib, Internal medicine, Genetics, medicine, Humans, Lung cancer, Pharmacology, Polymorphism, Genetic, business.industry, Haplotype, toxicity, medicine.disease, respiratory tract diseases, lung cancer, Haplotypes, Quinazolines, Cancer research, biology.protein, ATP-Binding Cassette Transporters, sense organs, business, Pharmacogenetics, Genome-Wide Association Study

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89d8dbdb68ab3323182687faf44033e8Test
https://doi.org/10.2217/pgs.10.172Test

المؤلفون: Ilaria Pastina, Sergio Ricci, Tristan M. Sissung, Romano Danesi, Douglas K. Price, William D. Figg, Cinzia Orlandini, Aldo Chioni, C. Cianci, Francesco Crea, Elisa Giovannetti

المساهمون: Medical oncology laboratory, CCA - Innovative therapy

المصدر: BMC Cancer, 10. BioMed Central
BMC Cancer
Pastina, I, Giovannetti, E, Chioni, A, Sissung, T M, Crea, F, Orlandini, C, Price, D K, Cianci, C, Figg, W D, Ricci, S & Danesi, R 2010, ' Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients ', BMC Cancer, vol. 10, pp. 511 . https://doi.org/10.1186/1471-2407-10-511Test
BMC Cancer, Vol 10, Iss 1, p 511 (2010)

مصطلحات موضوعية: Oncology, Male, medicine.medical_specialty, Cancer Research, Genotype, medicine.medical_treatment, CYP1B1, Antineoplastic Agents, Pharmacology, lcsh:RC254-282, Prostate cancer, Surgical oncology, Internal medicine, medicine, Genetics, Humans, pharmacogenetics, docetaxel, prostate cancer, Aged, Aged, 80 and over, Chemotherapy, Predictive marker, Polymorphism, Genetic, business.industry, Prostatic Neoplasms, Middle Aged, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Regimen, Treatment Outcome, Docetaxel, Drug Resistance, Neoplasm, Cytochrome P-450 CYP1B1, Multivariate Analysis, Taxoids, Aryl Hydrocarbon Hydroxylases, business, Pharmacogenetics, medicine.drug, Research Article

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8d4b7502b090bab3a294e49896ddfdcTest
https://research.vumc.nl/en/publications/e3d52b71-e2c3-4422-b169-fb26d797e27bTest

المؤلفون: Godefridus J. Peters, Maurizio Cantore, Ugo Boggi, Amir Avan, Andrea Mambrini, Niccola Funel, Paola Pacetti, Abolfazl Avan, Mina Maftouh, Elisa Giovannetti, Tessa Y S Le Large, Majid Ghayour-Mobarhan

المساهمون: Medical oncology laboratory, CCA - Quality of life

المصدر: PLoS ONE, 9(9):e108057. Public Library of Science
PLoS ONE
PLoS ONE, Vol 9, Iss 9, p e108057 (2014)
Avan, A, Avan, A, Le Large, T Y S, Mambrini, A, Funel, N, Maftouh, M, Ghayour-Mobarhan, M, Cantore, M, Boggi, U, Peters, G J, Pacetti, P & Giovannetti, E 2014, ' AKT1 and SELP Polymorphisms Predict the Risk of Developing Cachexia in Pancreatic Cancer Patients ', PLoS ONE, vol. 9, no. 9, e108057 . https://doi.org/10.1371/journal.pone.0108057Test

مصطلحات موضوعية: Adult, Genetic Markers, Male, Oncology, medicine.medical_specialty, Cachexia, P-selectin, Science, AKT1, Enzyme-Linked Immunosorbent Assay, Kaplan-Meier Estimate, Biology, Cohort Studies, Pancreatic Cancer, Pancreatic cancer, Internal medicine, Gastrointestinal Tumors, Genotype, Biopsy, Medicine and Health Sciences, medicine, Humans, Prospective cohort study, Genotyping, Aged, Clinical Genetics, Polymorphism, Genetic, Multidisciplinary, medicine.diagnostic_test, Cancers and Neoplasms, Middle Aged, Prognosis, medicine.disease, Pancreatic Neoplasms, P-Selectin, embryonic structures, Immunology, Medicine, Female, Proto-Oncogene Proteins c-akt, Research Article, Carcinoma, Pancreatic Ductal

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5325768d077a4520599395d928eccbd1Test
https://doi.org/10.1371/journal.pone.0108057Test

المؤلفون: Armando Santoro, Alfredo Falcone, Giuseppe Giaccone, Godefridus J. Peters, Jacobus A. Burgers, Elisa Giovannetti, Romano Danesi, Armida D'Incecco, Paolo Andrea Zucali, Carmelo Tibaldi, Filippo Cortesi, Egbert F. Smit

المساهمون: Medical oncology laboratory, Pulmonary medicine, CCA - Innovative therapy

المصدر: Web of Science
Molecular Cancer Therapeutics, 9(3), 581-593. American Association for Cancer Research Inc.
Giovannetti, E, Zucali, P A, Peters, G J, Cortesi, F, D'Incecco, A, Smit, E F, Falcone, A, Burgers, J A, Santoro, A, Danesi, R, Giaccone, G & Tibaldi, C 2010, ' Association of Polymorphisms in AKT1 and EGFR with Clinical Outcome and Toxicity in Non-Small Cell Lung Cancer Patients Treated with Gefitinib ', Molecular Cancer Therapeutics, vol. 9, no. 3, pp. 581-593 . https://doi.org/10.1158/1535-7163.MCT-09-0665Test
Università di Pisa-IRIS
Publons

مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Drug-Related Side Effects and Adverse Reactions, Population, Antineoplastic Agents, Pharmacology, Polymorphism, Single Nucleotide, Biomarkers, Pharmacological, Gefitinib, Internal medicine, Carcinoma, Non-Small-Cell Lung, Genotype, medicine, Humans, Epidermal growth factor receptor, Lung cancer, education, neoplasms, Survival analysis, Aged, Retrospective Studies, Aged, 80 and over, education.field_of_study, biology, business.industry, Middle Aged, medicine.disease, Prognosis, Survival Analysis, respiratory tract diseases, ErbB Receptors, Treatment Outcome, Drug Resistance, Neoplasm, biology.protein, Quinazolines, Biomarker (medicine), Female, business, Proto-Oncogene Proteins c-akt, Pharmacogenetics, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9fc4b7b10a929beaed8b02a975360daTest
https://publons.com/wos-op/publon/27272248Test/